Ertapenem Sodium (MK-0826) Versus Piperacillin/Tazobactam Sodium for the Treatment of Diabetic Foot Infections in Chinese Adults (MK-0826-061)

Clinical trial NCT01370616 · COMPLETED

Trial details

NCT number: NCT01370616
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infection; Diabetic Foot

Start date: 2011-09-02
Primary completion: 2013-12-08
Enrollment: 565

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.